Optometrist · Orlando, FL
NPI
1609150895
Since 2011
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6210 Twain St, Unit 103
Orlando, FL, 32835
Phone (646) 458-1661
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
784 services
Medicare patients, 2024
291
Average age 77
Drug cost, 2024
$915K
2,480 prescriptions
Company payments, 2025
$1,311
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Devin Singh was code 92014 (ophthalmological e&m), 303 times for 239 patients. In total Devin Singh billed 784 services in 18 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 303 | 239 | $82.07 | $25K |
| 92250 Angiography | Office | 116 | 110 | $24.04 | $2,788 |
| 92083 Vision, Hearing, and Speech Services | Office | 83 | 78 | $43.57 | $3,617 |
| 92134 Computerized Ophthalmic Imaging | Office | 78 | 77 | $28.67 | $2,236 |
| 92133 Computerized Ophthalmic Imaging | Office | 67 | 67 | $25.25 | $1,692 |
| 92004 Ophthalmological E&M | Office | 49 | 49 | $96.59 | $4,733 |
| 99213 Office E&M - Established | Office | 22 | 22 | $70.38 | $1,548 |
| 92020 Ophthalmological E&M | Office | 17 | 14 | $19.60 | $333 |
| 99214 Office E&M - Established | Office | 16 | 13 | $99.38 | $1,590 |
By year: 2023 $40K for 612 services; 2024 $53K for 784 services.
Medicare prescription drug claims, 2024
In 2024, the drug Devin Singh prescribed most often to Medicare patients was Latanoprost, with 580 prescriptions and refills. In total Devin Singh wrote 2,480 Medicare prescriptions that cost $915K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 580 | 1,232 | 225 | $5,829 |
| Restasis Cyclosporine | 306 | 701 | 176 | $426K |
| Eysuvis Loteprednol Etabonate | 158 | 162 | 131 | $80K |
| Lumigan Bimatoprost | 148 | 245 | 65 | $63K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 141 | 303 | 59 | $1,730 |
| Brimonidine Tartrate Generic | 136 | 247 | 62 | $5,447 |
| Rhopressa Netarsudil Mesylate | 116 | 161 | 42 | $52K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 82 | 108 | 23 | $37K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 77 | 77 | 69 | $2,772 |
| Prednisolone Acetate Generic | 72 | 87 | 55 | $2,793 |
| Cyclosporine Generic | 66 | 150 | 46 | $47K |
| Timolol Maleate Generic | 62 | 112 | 25 | $681 |
| Dorzolamide Hcl Generic | 59 | 99 | 16 | $1,005 |
| Combigan Brimonidine Tartrate/Timolol | 55 | 88 | 15 | $19K |
| Xiidra Lifitegrast | 50 | 127 | 34 | $83K |
Brand drugs: 1,484 claims; generic drugs: 996 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Devin Singh $1,311 ($1,311 in general payments such as food, travel and fees) from 10 companies. The largest payer was Bausch & Lomb Americas Inc. with $378.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 7 | $378 |
| Harrow Eye, LLC | 5 | $207 |
| Alcon Vision LLC ALC | 5 | $201 |
| Abbvie Inc. ABBV | 8 | $195 |
| Oyster Point Pharma, Inc. | 3 | $94.3 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $73.39 |
| Dompe US, Inc. | 3 | $70.92 |
| Mallinckrodt Hospital Products Inc. | 1 | $32.3 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $31.42 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $27.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.